Kamel Boumali

Led strategic business development within a global clinical research organization (70+ countries), focusing on complex, multi-stakeholder engagements with biotech and mid-size pharma. Structured and negotiated outsourcing partnerships across key therapeutic areas, coordinating multi-country stakeholders in a highly matrixed environment.

Supported multi-country commercial engagements across Southern and Western Europe in a regulated outsourcing environment, aligning contractual scope with delivery and client expectations. Contributed to structuring and managing outsourcing agreements across clinical development, pharmacovigilance, and medical information services.

Led strategic partnerships and business development across Southern Europe and Benelux, supporting clients across clinical development and post-approval services. Built cross-border, cross-functional collaborations to align commercial and operational strategies for long-term partnerships.

Supported commercial engagements across France, Switzerland, and Belgium in a regulated, data-driven life sciences environment. Contributed to partnership development across the full lifecycle of evidence generation and market access solutions, ensuring alignment with client needs and regulatory frameworks in multi-country settings.

Supported development of strategic partnerships and co-development programs in a life sciences innovation environment focused on advanced human tissue technologies. Coordinated multi-stakeholder initiatives with academic and private-sector organizations to accelerate product development and shape early-stage commercialization and go-to-market approaches.

Managed international commercial engagements for a preclinical oncology research organization specializing in translational drug discovery and advanced in vivo models. Evaluated external oncology programs with internal scientific experts and led multi-geographical account management across Southern Europe and Eastern Europe, ensuring alignment between client needs, feasibility, and commercial stru

Supported commercial activities in pharmaceutical intelligence specializing in patent landscape analysis for the generics and life sciences industry. Provided insights on drug lifecycle and patent expiry opportunities across Europe, Middle East, Africa, CIS, and the Americas to support decision-making for pharmaceutical and public-sector stakeholders.

Supported primary care commercial activities across cardiometabolic and respiratory diseases, engaging healthcare professionals including general practitioners and specialists. Managed relationships across a defined territory (North Paris) to support product adoption and awareness within a regulated healthcare environment.

Provided field-based commercial support to pharmaceutical clients across primary and specialty care therapeutic areas including cardiology, gastroenterology, pneumology, and consumer health. Engaged healthcare practitioners in a defined territory (South Paris) to support dissemination of product information within a regulated environment.

Managed international co-development collaborations focused on drug delivery systems and drug repositioning. Coordinated multi-stakeholder projects across internal R&D, regulatory, clinical, marketing, and procurement functions, and supported governance and reporting with international pharmaceutical partners across multiple geographies.

DBA in Management & Entrepreneurship with a thesis on validating the repurposing of existing molecules for rare diseases using a platform combining blockchain and artificial intelligence, and assessing its impact on optimizing the clinical development process.

Master's program in Management of the Pharmaceutical Industry, focusing on client-centric project management approaches and stakeholder alignment. Developed expertise in forecasting, product lifecycle management, and identifying market opportunities, with recognition for a presentation on the future evolution of pharmaceutical distribution in France.

Post-graduate degree (DEA) in biological engineering, specialized in pharmaceutical engineering through coursework at the Faculty of Medicine.

Master's degree in animal cellular biology and physiology, with specialization in cellular disorders and drugs at the Faculty of Sciences.